Cargando...
Targeting tumor cells with antibodies enhances anti-tumor immunity
Tumor-targeting antibodies were initially defined as a group of therapeutic monoclonal antibodies (mAb) that recognize tumor-specific membrane proteins, block cell signaling, and induce tumor-killing through Fc-driven innate immune responses. However, in the past decade, ample evidence has shown tha...
Guardado en:
| Publicado en: | Biophys Rep |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer Berlin Heidelberg
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6245233/ https://ncbi.nlm.nih.gov/pubmed/30533489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41048-018-0070-2 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|